Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP)

Koontz, Bridget F.; Levine, Erica; McSherry, Frances; Niedzwiecki, Donna; Sutton, Linda; Dale, Tykeytra; Streicher, Martin; Rushing, Christel; Owen, Lynda; Kraus, William E.; Bennett, Gary G.; Pollak, Kathryn I.

doi:10.1007/s00520-021-06281-y

Cited by 6 publications

(7 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ICanSTEP [ 40 ] consists of an EMA module (activity tracker) and a Smart-EMI component (daily text messages personalized to their activity level) to improve and promote physical activity through self-activation in cancer survivors. A nonrandomized prospective intervention trial was performed on 30 patients, and while the primary endpoint was the 6 min walk test at 3 months, the secondary result was a significant improvement in the Beck Depression Inventory.…”

Section: Resultsmentioning

confidence: 99%

“…MoodBuster [36] Mobilyze! [28] Therap-I [37] PRIME [38] MASS [39] ICanStep [40] Hiroshima HN [41] General design of SMART EMI is recalled in Figure 1.…”

Section: Smart-emimentioning

confidence: 99%

“…MoodBuster [36] Mobilyze! [28] Therap-I [37] PRIME [38] MASS [39] ICanStep [40] Hiroshima HN [41] General design of SMART EMI is recalled in Figure 1. Real life training ("in situ") appears highly relevant for learning or to regain healthy behaviors, since depressed people regularly switch from goal-directed behavior to habits [30],…”

Section: Smart-emimentioning

confidence: 99%

See 2 more Smart Citations

In Search of Digital Dopamine: How Apps Can Motivate Depressed Patients, a Review and Conceptual Analysis

et al. 2021

View full text Add to dashboard Cite

Introduction: Depression is highly prevalent and causes considerable suffering and disease burden despite the existence of wide-ranging treatment options. Momentary assessment is a promising tool in the management of psychiatric disorders, and particularly depression. It allows for a real-time evaluation of symptoms and an earlier detection of relapse or treatment efficacy. Treating the motivational and hedonic aspects of depression is a key target reported in the literature, but it is time-consuming in terms of human resources. Digital Applications offer a major opportunity to indirectly regulate impaired motivational circuits through dopaminergic pathways. Objective: The main objective of this review was twofold: (1) propose a conceptual and critical review of the literature regarding the theoretical and technical principles of digital applications focused on motivation in depression, activating dopamine, and (2) suggest recommendations on the relevance of using these tools and their potential place in the treatment of depression. Material and Methods: A search for words related to “dopamine”, “depression”, “smartphone apps”, “digital phenotype” has been conducted on PubMed. Results: Ecological momentary interventions (EMIs) differ from traditional treatments by providing relevant, useful intervention strategies in the context of people’s daily lives. EMIs triggered by ecological momentary assessment (EMA) are called “Smart-EMI”. Smart-EMIs can mimic the “dopamine reward system” if the intervention is tailored for motivation or hedonic enhancement, and it has been shown that a simple reward (such as a digital badge) can increase motivation. Discussion: The various studies presented support the potential interest of digital health in effectively motivating depressed patients to adopt therapeutic activation behaviors. Finding effective ways to integrate EMIs with human-provided therapeutic support may ultimately yield the most efficient and effective intervention method. This approach could be a helpful tool to increase adherence and motivation. Conclusion: Smartphone apps can motivate depressed patients by enhancing dopamine, offering the opportunity to enhance motivation and behavioral changes, although longer term studies are still needed.

show abstract

Section: Resultsmentioning

confidence: 99%

“…MoodBuster [36] Mobilyze! [28] Therap-I [37] PRIME [38] MASS [39] ICanStep [40] Hiroshima HN [41] General design of SMART EMI is recalled in Figure 1.…”

Section: Smart-emimentioning

confidence: 99%

See 1 more Smart Citation

In Search of Digital Dopamine: How Apps Can Motivate Depressed Patients, a Review and Conceptual Analysis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The studies included in this review inform prognostication by examining physical activity levels and its correlates to identify potential patient profiles and their association with various clinical outcomes. These outcomes include physical well-being measures such as anthropometric measures, 31 , 45 , 51 , 63 , 64 , 70 , 82 , 106 , 109 , 113 , 124 , 179 performance status, 26 , 39 , 56 , 62 , 67 , 85 , 120 , 128 motor function, 71 , 92 , 208 functional recovery, 17 , 117 bone health, 162 and symptoms or pain, 12 , 27 , 38 , 39 , 41 , 51 , 56 , 63 , 99 , 126 , 163 quality of life 13-16 , 18 , 24 , 25 , 29 , 32 , 34 , 37 , 39 , 41 , 46 , 47 , 53 , 60 , 67 , 69 , 75 , 80 , 87 , 93 , 101 , 111 , 113 , 114 , …”

Section: Discussionmentioning

confidence: 99%

The Use of Wearable Devices in Oncology Patients: A Systematic Review

Chow,

Drkulec,

et al. 2023

The Oncologist

View full text Add to dashboard Cite

Introduction The aim of this systematic review was to summarize the current literature on wearable technologies in oncology patients for the purpose of prognostication, treatment monitoring, and rehabilitation planning. Methods A search was conducted in Medline ALL, Cochrane Central Register of Controlled Trials, Embase, Emcare, CINAHL, Scopus, and Web of Science, up until February 2022. Articles were included if they reported on consumer grade and/or non-commercial wearable devices in the setting of either prognostication, treatment monitoring or rehabilitation. Results We found 199 studies reporting on 18 513 patients suitable for inclusion. One hundred and eleven studies used wearable device data primarily for the purposes of rehabilitation, 68 for treatment monitoring, and 20 for prognostication. The most commonly-reported brands of wearable devices were ActiGraph (71 studies; 36%), Fitbit (37 studies; 19%), Garmin (13 studies; 7%), and ActivPAL (11 studies; 6%). Daily minutes of physical activity were measured in 121 studies (61%), and daily step counts were measured in 93 studies (47%). Adherence was reported in 86 studies, and ranged from 40% to 100%; of these, 63 (74%) reported adherence in excess of 80%. Conclusion Wearable devices may provide valuable data for the purposes of treatment monitoring, prognostication, and rehabilitation. Future studies should investigate live-time monitoring of collected data, which may facilitate directed interventions.

show abstract

“…Many factors can affect the HRQoL of patients with LUAD, and most attention is paid to modifiable behavioral factors [13]. Physical activity is a modifiable factor that is related to the prognosis of chronic diseases and cancer [14][15][16]. Previous studies have found that exercise prior to treatment or during rehabilitation can help improve outcomes of surgery, including cancerrelated fatigue and dyspnea [17][18][19].…”

Section: Introductionmentioning

confidence: 99%

Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma

Zhuang

Liu

et al. 2022

J Cancer Surviv

View full text Add to dashboard Cite

Background and purpose Health-related quality of life (HRQoL) is a key aspect of care for cancer survivors that can be improved by physical activity. Our aim was to explore the relationship between physical activity and time to deterioration (TTD) of the HRQoL in patients with lung adenocarcinoma (LUAD). Methods We conducted a hospital-based prospective study. The International Physical Activity Questionnaire long-form (IPAQ-L) was used to investigate the pre-treatment physical activity levels, and the EORTC Quality of Life Questionnaire version 3.0 (EORTC QLQ-C30) and EORTC Quality of Life Questionnaire-Lung Cancer (EORTC QLQ-LC13) were used to assess HRQoL at baseline and during follow-up. The QoLR package was used to calculate the HRQoL scores and determine TTD events (minimal clinically important difference=5 points). The effect of physical activity on the HRQoL was assessed using Cox regression analysis. Results For EORTC QLQ-C30, TTD events of physical functioning (PF) and dyspnea (DY) in functional scales and symptom scales were the most common during follow-up. Pre-treatment physical activity was found to significantly delay TTD of insomnia (HR=0.635, 95%CI: 0.437–0.922, P=0.017) and diarrhea (HR=0.475, 95%CI: 0.291–0.774, P=0.003). For EORTC QLQ-LC13 scales, deterioration of dyspnea (LC-DY) was the most common event. Physical activity was found to delay the TTD of dyspnea (HR=0.654, 95%CI: 0.474–0.903, P=0.010), sore mouth (HR=0.457, 95%CI: 0.244–0.856, P=0.015), and dysphagia (HR=0.315, 95%CI: 0.172–0.580, P<0.001). Conclusions Pre-treatment physical activity of LUAD patients may delay the TTD of multiple HRQoL indicators in EORTC QLQ-C30 and EORTC QLQ-LC13. Implication for Cancer Survivors Health-related quality of life (HRQoL) is a key aspect of care for cancer survivors (someone who is living with or beyond cancer), that can be improved by physical activity. Our aim was to explore the relationship between physical activity and time to deterioration (TTD) of the HRQoL in patients with lung adenocarcinoma (LUAD).

show abstract

Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP)

Cited by 6 publications

References 39 publications

In Search of Digital Dopamine: How Apps Can Motivate Depressed Patients, a Review and Conceptual Analysis

In Search of Digital Dopamine: How Apps Can Motivate Depressed Patients, a Review and Conceptual Analysis

The Use of Wearable Devices in Oncology Patients: A Systematic Review

Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma

Contact Info

Product

Resources

About